SCHEMBL19862589

SCHEMBL19862589

c1ccc(-c2cc(-c3ccccc3)nc(-c3ccc(-c4cccc(-n5c6ccccc6c6ccc(-c7cccc(-n8c9ccccc9c9ccccc98)c7)cc65)c4)cc3)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 8/20 0.44
▸ KMT2A Q03164 8/20 0.44
▸ HPGD P15428 6/20 0.44
▸ ALDH1A1 P00352 5/20 0.44
▸ MAPT P10636 5/20 0.44
▸ NTSR1 P30989 1/20 0.44
▸ KDM4E B2RXH2 4/20 0.44
▸ ATM Q13315 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ LMNA P02545 2/20 0.43
▸ GLA P06280 1/20 0.43
▸ ADORA2A P29274 1/20 0.39
▸ ADORA1 P30542 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ MAOA P21397 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ AVPR1A P37288 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15458364 0.99 MEN1 (0.43) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL17714787 0.99 KDM4E (0.46) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL17714742 0.99 KDM4E (0.46) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL20290666 0.99 MEN1 (0.45) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL20291326 0.99 MEN1 (0.45) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL15458371 0.99 MEN1 (0.43) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL14748853 0.99 MEN1 (0.45) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL20290605 0.97 MEN1 (0.44) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL14748849 0.97 KDM4E (0.45) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL15458378 0.97 MEN1 (0.44) MEN1KMT2AHPGDALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10559761-B2 Light-emitting material, and organic electroluminescent device KYULUX, INC. (JP) 2020-02-11 — — US disclosed
US-20180047915-A1 LIGHT-EMITTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE KYULUX, INC. (JP) 2018-02-15 — — US disclosed
US-20180047915-A1 LIGHT-EMITTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE KYULUX, INC. (JP) 2018-02-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180047915-A1 LIGHT-EMITTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE EML4, L1CAM, CRY1 MEN1 1656/4885KMT2A 2360/4885HPGD 3451/4885
US-10559761-B2 Light-emitting material, and organic electroluminescent device EML4, L1CAM, CRY1 MEN1 1656/4885KMT2A 2360/4885HPGD 3451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback